A New Risk Index Combining -Dimer, Fibrinogen, HE4, and CA199 Differentiates Suspecting Endometrial Cancer From Patients With Abnormal Vaginal Bleeding or Discharge
Purpose: To establish an efficient new risk index for screening patients with endometrial cancer from patients with abnormal vaginal bleeding or discharge.Method: A weboost splitter total of 254 patients with abnormal vaginal bleeding or discharge were included in this study.Several candidate markers, including HE4, CA125, CA199, CA153, AFP, CEA, d